![](/img/cover-not-exists.png)
New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34+cells
Maria Alessandra Santucci, Manuela Mancini, Valentina Corradi, Ilaria lacobucci, Giovanni Martinelli, Maurizio Botta, Silvia SchenoneVolume:
28
Language:
english
Pages:
3
DOI:
10.1007/s10637-009-9294-9
Date:
December, 2010
File:
PDF, 145 KB
english, 2010